Daniel B Costa, MD
Professor
Medical Oncology
Contact Information
| Office: | CL-0428A |
| Phone: | 617-667-9236 |
| Fax: | 617-975-5665 |
| Email: | dbcosta@bidmc.harvard.edu |
| Address: | 330 Brookline Ave; CL-0428A
Boston, MA 02215 |
Advanced Degree And Training
| Year | Institution | Area or Rank |
| 2000 | FMRP - University of Sao Paulo - Brazil | MD |
| 2001 | Yale University School of Medicine | Intern Medicine |
| 2002 | Yale University School of Medicine | Resident Medicine |
| 2004 | Beth Israel Deaconess Medical Center - Harvard Medical School | Fellow Hem Oncology |
| 2004 | State University of Campinas - UNICAMP | PhD |
| 2007 | Beth Israel Deaconess Medical Center | Hem Oncology Staff |
| 2007 | Harvard Medical School | Instructor Med |
| 2007 | Harvard-MIT Division of Health Sciences and Technology | MMSc Fellow Clin Invest |
| 2010 | Harvard Medical School | Assistant Professor Med |
Areas of Interest
| 1 Cancer |
Major Research Theme
|
Lung cancer is the leading cause of death from cancer in the United States. Better understanding of oncogenes and tumor suppressor genes involved in lung cancer hold the promise of improving clinical care of afflicted patients. Prior work from our group has focused on transcription factors involved in lung cancer and mechanisms of sensitivity/resistance of oncogene kinases (such as EGFR, ALK, KRAS) to tyrosine kinase inhibitors in non-small-cell lung cancer. Our group is also part of the clinical research effort at DFHCC, with a focus in non-small-cell lung cancer. We are part of the NIH/NCI-funded SPORE in Lung Cancer at DFHCC. (co-investigators: Daniel G. Tenen, MD, Mark Huberman, MD and Susumu Kobayashi, MD, PhD) |
Publications
External Recognition
| 2007 Young Investigator Award – American Society of Clinical Oncology (ASCO) 2007 AACR Fellowship in Translational Lung Cancer Research - American Association for Cancer Research (AACR)-AstraZeneca-Cancer Research and Prevention Foundation 2009 Career Development Award - American Society of Clinical Oncology (ASCO) |
Major Collaborative Activities
| Co-Investigator - Lung Cancer SPORE DFHCC (2P50 CA090578-06, overall PI: Johnson DFCI): Project 2. “Airway transcription factors in the pathogenesis and treatment of lung cancer” |
Investigator's Lab Web Site
| Research Lab URL | None listed |
| Harvard Catalyst Site: | Costa Harvard Catalyst Web Site |
